Summit Financial Strategies’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
Summit Financial Strategies's LLY Position: Q2 2026 in Review
Summit Financial Strategies reduced its Eli Lilly (LLY) stake by 2.5% in Q2 2026, selling an estimated $46K and leaving 1,755 shares worth $2.1M. The position accounts for 0.15% of the portfolio, ranked #51.
Summit Financial Strategies first reported a position in LLY in Q2 2021 and has held it in 21 quarters since. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Summit Financial Strategies held 1,755 shares of Eli Lilly worth $2.1M as of Q2 2026.
- Summit Financial Strategies sold 45 Eli Lilly shares in Q2 2026, an estimated $46K.
- Eli Lilly made up 0.15% of Summit Financial Strategies's portfolio in Q2 2026, its #51 holding.
- Summit Financial Strategies first reported a position in Eli Lilly in Q2 2021 and has held it in 21 quarters since.
- 2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Summit Financial Strategies's 13F filing for Q2 2026, filed 24 Jul 2026.